Latest Commercialisation News

Global Uranium and Enrichment Limited has completed a major 2025 drilling campaign at its Pine Ridge Uranium Project in Wyoming, confirming widespread uranium mineralisation across multiple sandstone horizons. The results reinforce the project's potential for in-situ recovery development in a premier US uranium basin.

Argosy Minerals has completed detailed engineering for a 40MW energy infrastructure project to supply its Rincon Lithium Project in Argentina, marking a key step towards commercialisation and cost efficiency.

Aristocrat Leisure and Light & Wonder have resolved a high-profile intellectual property dispute with a $190 million settlement and the withdrawal of contested games worldwide.

St George Mining reports exceptional drilling results at its Araxá Rare Earths and Niobium Project, significantly expanding its resource footprint, alongside a successful $72.5 million capital raise to fund ongoing development.

Mesoblast Limited reports a 60% jump in Ryoncil sales for the December quarter, underpinned by a new $125 million financing facility that strengthens its balance sheet and strategic flexibility.

NuEnergy Gas Limited has inked a fully funded collaboration with PT Beijing Energy Linking to scale its Tanjung Enim coalbed methane project from early sales to a major 25 MMSCFD production plateau.

Chariot Resources has signed a non-binding MOU with Fujian Jinjianqiao to explore offtake, financing, and local processing for its Nigerian lithium projects, aiming to accelerate commercialisation.

BPH Global has refined its Project 6-7 R&D program to concentrate on recovering gold and silver from seaweed, aiming to fast-track commercialisation of this innovative bio-mining approach.

Neuren Pharmaceuticals has published promising Phase 2 trial results for NNZ-2591 in Phelan-McDermid syndrome, underpinning its ongoing Phase 3 Koala trial recruiting in the US.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

UC San Diego Health has begun clinical use of 4DMedical’s CT – VQ™, marking the fourth leading US academic medical centre to adopt this innovative lung imaging technology since FDA clearance. This milestone underscores 4DMedical’s rapid commercial traction and growing influence in respiratory diagnostics.

Island Pharmaceuticals has been granted a key US patent for Galidesivir, extending intellectual property protection through 2031 for treating filoviridae viruses including Marburg and Ebola. This milestone aligns with the company’s clinical development strategy and recent FDA regulatory progress.